Falk Nimmerjahn
www.genetik.nat.uni-erlangen.de
0000-0002-5418-316X
Friedrich-Alexander-University Erlangen-Nürnberg
3 papers found
Refreshing results…
Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
Select hyperactivating NLRP3 ligands enhance the T H 1- and T H 17-inducing potential of human type 2 conventional dendritic cells
Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in Lyme arthritis
Missing publications? Search for publications with a matching author name.